Correlation Between VentriPoint Diagnostics and Stantec

Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and Stantec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and Stantec into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between VentriPoint Diagnostics and Stantec, you can compare the effects of market volatilities on VentriPoint Diagnostics and Stantec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of Stantec. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and Stantec.

Diversification Opportunities for VentriPoint Diagnostics and Stantec

-0.29

Correlation Coefficient

VentriPoint Diagnostics  Stantec

Very good diversification

The 3 months correlation between VentriPoint and Stantec is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and Stantec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stantec and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with Stantec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stantec has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and Stantec go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and Stantec

Assuming the 90 days horizon VentriPoint Diagnostics is expected to generate 6.29 times more return on investment than Stantec. However, VentriPoint Diagnostics is 6.29 times more volatile than Stantec. It trades about 0.12 of its potential returns per unit of risk. Stantec is currently generating about -0.33 per unit of risk. If you would invest  9.00  in VentriPoint Diagnostics on October 15, 2024 and sell it today you would earn a total of  1.00  from holding VentriPoint Diagnostics or generate 11.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

VentriPoint Diagnostics  vs.  Stantec

VentriPoint Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Stantec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stantec has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Stantec is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with VentriPoint Diagnostics and Stantec

The main advantage of trading using opposite VentriPoint Diagnostics and Stantec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, Stantec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stantec will offset losses from the drop in Stantec's long position.

The idea behind VentriPoint Diagnostics and Stantec pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.